Through
4/26
After examining data from large trials of autoimmune-disease medications called Interleukin-17 inhibitors, researchers found individuals who took these treatments were more likely to develop symptoms associated with respiratory-tract infections.
New Penn Wharton Budget Model predicts 212,000 additional deaths related to the coronavirus but the recouping of around 18 million jobs by July 15 if all states fully reopen.
Researchers at Penn Medicine are working to understand how the COVID-19 virus works, and are finding it has unusual range in symptoms and behavior, including a loss of smell in some patients.
Putting some of their regular research projects on the back burner, researchers around Penn are digging into unknowns about the novel coronavirus from their deep and varied perspectives.
Canine surveillance could play key role as the United States reopens and anticipates possible second wave amid virus fears.
The Penn Wharton Budget Model analyzed the health and economic effects of states both partially and fully reopening schools, businesses and restaurants.
Penn experts discuss the limitations of commercial antibody tests, how scientists are assessing the true scale of COVID-19 infections, and what studies are being done to see who might now be immune to the novel coronavirus.
School of Nursing faculty member and LDI Senior Fellow Adriana Perez conducts research in two of the Philadelphia area’s largest Latino communities and provides insights into how COVID-19 is impacting each.
Wharton professor Adi Wyner digs into the statistics about the COVID-19 outbreak and offers insights into what the numbers mean.
A two-part research initiative using plasma from people who’ve recovered from the virus will investigate how the therapy works for moderately and severely ill patients.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →